Media coverage of security ops under serious consideration: Arun Jaitley

January 19, 2015

Arun Jaitley media

New Delhi, Jan 19: Terming it as the “desire of the media to be an actor” while reporting from scenes of security operations, Union I&B Minister Arun Jaitley Sunday said the country’s security and defence establishments were of the view that this cannot be allowed and that the matter was under “serious and very advanced consideration” of the government.

“How do you report instances where insurgent action is on… where a security operation is in full swing? Should the media go into the midst of the scene and therefore report from the spot as to what is happening. Or, should the media have some constraints?” Jaitley asked. He was delivering the first Justice J S Verma memorial lecture on ‘Freedom & Responsibility of Media’ here.

“We’ve have intelligence information to say that because Indian television had decided to bring the 26/11 reporting almost in real-time as to what action was being taken, the terrorists inside the hotels were being informed on their satellite phones by their handlers as to what the Indian security forces were doing,” Jaitley said.

“Our security agencies and the Ministry of Defence are clearly of the view that this cannot be allowed. And, therefore, during the limited duration when the security operation is on, a very strict discipline on the kind of reporting which is to take place from the place of the incident will have to be maintained. This issue is under serious and very advanced consideration of the government,” he added.

On instances of trial by the media, Jaitley said, “I am constrained to observe that certain trial courts are under tremendous pressure, particularly in high-profile cases where the media has conducted a parallel trial and almost declared somebody guilty or innocent.”

The minister also underlined that the “privacy of individuals” even in “high-profile cases” needed to be respected and that “media will have to seriously introspect as to what extent it should go to” when dealing with “areas which have no bearing on larger public interest” but “can only add some spice to the content of the report”.

On the “sub judice rule”, Jaitley said in larger matters of public interest, one cannot have a complete gag on the media “merely because an issue is pending in a court”. He, however, added that if there are “issues relating to individual culpability — where innocence or guilt has to be judged — the parallel trial concept prejudices the entire environment around which a person is to get justice”.

The minister also said any move where the government gets into “disciplining media organisations” may have its own pitfalls.

“It may have its own pitfalls if the government gets into the business of disciplining media organisations. I would be more comfortable if the viewers or the readers decide that,” Jaitley said.

On the issue of cross-holdings in the media, Jaitley said most jurisdictions the world over ban cross-holding rights. “If you own newspapers, you cannot own channels. If you own channel, then you can’t own the medium through which a channel is telecast, that is, the cable or DTH. We have no such restrictions,” he said.

Stating that the media today has a responsibility “to be credible, to be fair, to be an educator on sensitive issues and to maintain the highest standards of financial integrity”, Jaitley added that the “media will have to be extra careful where its own interests are involved and therefore wherever there is a possibility of conflict of interest, adequate disclosure to that effect has to be made”.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 2,2020

Lucknow, Jul 2: Senior BJP leader Uma Bharti Thursday appeared in person before a special court here conducting trial in the 1992 Babri mosque demolition case.      

The special CBI court is currently recording the statements of 32 accused under CrPC section 313 (court's power to examine the accused), a stage in the trial that follows the examination of prosecution witnesses.

The 61-year-old saffron clad BJP leader is the 19th accused to depose before the court in the over 27-year-old case. Thirteen other alleged accused, including former deputy prime minister LK Advani and senior BJP leaders MM Joshi and Kalyan Singh are yet to be examined at this stage. Their lawyers have indicated to the CBI court that they prefer to appear through video conferencing. 

The mosque in Ayodhya was demolished in December 1992 by 'kar sevaks' who claimed that an ancient Ram temple had stood on the same site. The CBI court is conducting day-to-day hearings to complete the trial by August 31, as directed by the Supreme Court.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 30,2020

Bengaluru, Apr 30: Shares of Glenmark Pharmaceuticals Ltd rose almost 9% on Thursday after the Indian drugmaker got an approval to conduct clinical trials with antiviral drug favipiravir, seen as a potential treatment for COVID-19.

Favipiravir, manufactured under the brand name Avigan by a unit of Japan's Fujifilm Holdings Corp and approved for use as an anti-flu drug in the Asian island country in 2014, has been effective, with no obvious side-effects, in helping coronavirus patients recover, a Chinese official told reporters at a news conference last month.

"After having successfully developed the API and the formulations ... Glenmark is all geared to immediately begin clinical trials on favipiravir on COVID-19 patients in India," Sushrut Kulkarni, executive vice-president for Global R&D, Glenmark Pharmaceuticals, said in a statement. 

The Drug Controller General of India, the country's drug regulator, did not immediately respond to Reuters request for comment.

On Wednesday, another Indian pharmaceutical company, Strides Pharma Science Ltd, said it had developed and commercialized favipiravir antiviral tablets, and had applied to Indian drug authorities to start trials.

Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%, as of 0407 GMT.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 8,2020

New Delhi, Apr 8: The Supreme Court on Wednesday suggested that all tests to identify coronavirus positive patients should be conducted free of cost and asked the Central government to look into creating a mechanism for providing reimbursement for the same.

A bench headed by Justice Ashok Bhushan, while hearing a PIL via video-conferencing, suggested that the test should be conducted free of cost in the identified private laboratories and said that the court will pass appropriate order on the matter.

The apex court was hearing a PIL filed by lawyer and petitioner Shashank Deo Sudhi seeking direction to the Centre and other respective authorities to provide free of cost the testing facility for COVID-19 to all citizens in the country.

Solicitor General Tushar Mehta submitted that 118 laboratories were doing 15,000 test capacity per day and added that 47 private laboratory chains have also been involved for the same.

During the hearing, the court asked the Centre to ensure private labs don't charge a high amount for the test and suggested that the government can create an effective mechanism for reimbursement from the government for tests.

Mehta said that they will look into the suggestion and will try to devise what can be done best.

Sudhi, on the other hand, submitted that testing of coronavirus is very expensive and therefore the Central government should take all necessary steps to provide free of cost the testing facility for COVID-19 kits and others to all citizens in the country.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.